This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bettermann, H. Articles by Levy, D. Search for Related Content PubMed PubMed Citation Articles by Bettermann, H. Articles by Levy, D. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure

(Hypertension. 2000;35:e6.)
© 2000 American Heart Association, Inc.

Hypertension Electronic Pages

Heart Rate Variability: How to Assess Effects of Mild Therapies on Autonomic Control in Small Groups of Mild and Borderline Hypertensives?

Henrik Bettermann; Dirk Cysarz; Hans Christoph Kümmell

Department of Clinical Research, Gemeinschaftskrankenhaus, Herdecke, Germany

	Introduction

 
To the Editor:

In their recent retrospective study, Singh et al¹ could demonstrate on the basis of the impressively huge data set of the Framingham Heart Study that, first, short-term heart rate variability (HRV) is reduced in men and women with systemic hypertension and, second, among normotensive men, lower HRV was associated with a greater risk for developing hypertension. The authors concluded that autonomic dysregulation is present in the early stage of hypertension. Their findings are important but were not very surprising because the reported HRV reduction was generally in accordance with findings of earlier studies.² However, what they inevitably left out of consideration was the analysis of the diurnal variation of blood pressure, heart rate, and their respective variabilities. Particularly, the asleep/awake ratios of blood pressure are probably more specific and sensitive than temporary daytime parameters.³ From the methodical point of view, the study was characterized by the strong and uncompromising use of statistics, but unfortunately without showing any raw data, eg, by using scatter or box plots of the blood pressure and HRV data. Moreover, one important question remained unanswered: How did the HRV parameters and the covariates change during 4 years of follow-up?

Independently and without knowledge of the results from the above study, we also studied the differences of linear and nonlinear HRV parameters in (only) 25 essential nontreated hypertensive subjects with respect to their status of hypertension. The study was carried out from Spring to Fall 1998, and the results are not yet published. The . . . [Full Text of this Article]

Jagmeet Singh, MD, DPhil

National Heart, Lung, and Blood Institute’s Framingham Heart Study Framingham, Massachusetts

Martin Larson, DSc

Boston University School of Medicine Boston, Massachusetts

Daniel Levy, MD

Massachusetts General Hospital Harvard Medical School, Boston, Massachusetts